Latest News

STAT Plus: Pharmalittle: Amazon wants to sell drugs directly through PillPack; Merck hunts for its next CEO

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite a hectic schedule this week filled with meetings and a speaking engagement. This explains the sporadic posting, other than the usual morning missives. Nonetheless, we are motoring along, thanks to a few cups of stimulation. So time to get on with it. Here are a few items of interest to help you cope with your own busy schedule. Hope you conquer the world today and do keep us in mind when something interesting pops. …

Merck (MRK) has begun to prepare for the departure of chief executive officer Ken Frazier and is focusing its search for an eventual successor on a pool of internal candidates, Bloomberg News writes. Last September, Merck disclosed that Frazier would remain beyond 2019, rolling back a policy that would have required him to retire when he turns 65 in December. But now, Merck is laying the groundwork for his exit, as well as that of its seasoned research and development leader Roger Perlmutter, who is 66.

Continue to STAT Plus to read the full story…

Source link

Related posts

Study finds link between DNA methylation and non-alcoholic fatty liver disease


Researchers identify sepsis symptoms that contribute to patient mortality


Parents Can Help Their Sleep-Deprived Teens


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy